Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Transcriptomic, Genomic, and Microenvironmental Heterogeneity in pancreatic precancer: subtyping, classification, and cross-comparison

Award Number: K99CA312671
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 06/01/2026
PERIOD OF PERFORMANCE END DATE: 05/31/2028

Group Awards By:

View Award Description

Transcriptomic, Genomic, and Microenvironmental Heterogeneity in pancreatic precancer: subtyping, classification, and cross-comparison - Project Summary Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer that arises from precancerous lesions, including intraductal papillary mucinous neoplasms (IPMNs) and pancreatic intraepithelial neoplasia (PanIN)1,2. IPMN lesions are highly prevalent in the aging pancreas and detectable on early abdominal imaging, with only some progressing to PDAC3,4. Early detection and differentiation of progressive versus indolent precancers for therapeutic intervention is critical to improving PDAC outcomes. My long-term objective is to elucidate the molecular mechanisms driving precancer progression and develop tools to stratify high-risk lesions to enable early intervention and improve patient outcomes. To identify high-risk lesions, the heterogeneity of IPMNs must first be characterized through the definition of robust, multi-omic phenotypes from matched genomic and transcriptomic data to uncover transcriptional programs and genomic drivers of dysplastic progression. To distinguish between cohort-specific, tissue- specific, and pan-precancer phenotypes, I propose the cross-comparison of phenotypes from different tissues via the development of a novel classification algorithm and the dissemination of results in a public, web-based platform. Finally, I propose to adapt an algorithm developed in my Ph.D. to quantify single-cell degree of differentiation to the study of dysplastic progression through further integrative multi-omic analysis of IPMN data, including epigenomic information. By identifying drivers of de-differentiation and dysplastic progression and developing algorithms to characterize the highly heterogenous IPMN landscape, this project addresses a critical gap in early detection and prevention of PDAC, a cancer with a 5-year survival rate below 5%2. The innovative integration of multi-omics, computational biology, and spatial modeling will yield biomarkers and therapeutic targets for early intervention and serve as the foundation for my independent research program in cancer data science.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $123,823 )
2026	2026	UNIVERSITY OF MARYLAND, BALTIMORE	220 ARCH ST OFC LEVEL2	BALTIMORE	MD	21201	BALTIMORE CITY	USA	Cancer Research Manpower	000	1	5/7/2026	NEW	$123,823
														Subtotal = $123,823

Grand Total All Awards = $123,823

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Transcriptomic, Genomic, and Microenvironmental Heterogeneity in pancreatic precancer: subtyping, classification, and cross-comparison

Award Number: K99CA312671

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 06/01/2026

PERIOD OF PERFORMANCE END DATE: 05/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer